TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Oncology Drugs Market 2024-2030 by Player, Region, Type, Application and Sales Channel

Oncology Drugs Market 2024-2030 by Player, Region, Type, Application and Sales Channel

  • Category:Life Sciences
  • Published on : 03 June 2024
  • Pages :105
  • Formats:
  • Report Code:SMR-7957206

The global Oncology Drugs market size is estimated to be $178.5 billion in 2023, it will reach $431.3 billion by 2032, growing at a CAGR of 10.3% during the forecast period from 2024 to 2032.

One of the key trends in the Indian Oncology Drugs market is the increasing adoption of targeted therapies. These drugs are designed to target specific molecules or pathways involved in the growth and spread of cancer cells, and have been shown to be more effective and less toxic than traditional chemotherapy drugs.Another trend in the market is the growing importance of biosimilars.

Healthcare Providers

  • Oncologists and Specialists

    • Global Count: As of 2023, there are approximately 150,000 practicing oncologists worldwide. The United States alone has around 13,000 oncologists.
    • Workload: On average, oncologists in the U.S. see about 200-300 new cancer patients per year, with each having a caseload of around 1,000 patients annually.
  • Hospitals and Clinics

    • Specialized Cancer Centers: Globally, there are over 5,000 specialized cancer treatment centers, with the U.S. housing around 1,500 of these facilities.
    • General Hospitals: About 20% of general hospitals have dedicated oncology departments, which are critical in delivering cancer care to a broader population.
  • Nurses and Support Staff

    • Oncology Nurses: There are approximately 50,000 oncology nurses in the U.S., with each nurse managing about 3-4 cancer patients per shift.
    • Pharmacists: Specialized oncology pharmacists play a key role, with around 5,000 pharmacists in the U.S. focusing on cancer medication management.

Patients

  • Treatment Demographics
    • Age Distribution: The median age for cancer diagnosis is 66 years. However, the incidence of cancer in younger populations (ages 20-49) is also significant, accounting for about 10% of all cases.
    • Gender Distribution: Men have a slightly higher incidence rate of cancer than women, with lifetime risk being 39.3% for men and 37.7% for women.

Medication Utilization

 
  • Treatment Adoption

    • Chemotherapy: Still a cornerstone of cancer treatment, with over 60% of cancer patients undergoing some form of chemotherapy during their treatment course.
    • Targeted Therapy: Increasing in popularity, with about 25% of cancer treatments involving targeted drugs that specifically attack cancer cells.
    • Immunotherapy: A rapidly growing field, with around 15% of cancer patients receiving immunotherapy, expected to rise due to its promising outcomes.

Economic Impact

 
  • Insurance and Accessibility

    • Coverage: Approximately 90% of cancer patients in developed countries have some form of health insurance coverage. However, accessibility to the latest treatments varies, with about 20% of patients facing delays or denials in coverage for new therapies.
    • Global Disparities: In low and middle-income countries, only about 30% of patients have access to basic cancer treatments, highlighting a significant gap in global healthcare equity.

Future Outlook

  • Innovations and Research

    • Pipeline Drugs: Over 1,200 oncology drugs are currently in the development pipeline, with a significant focus on personalized medicine and immunotherapy.
    • Clinical Trials: There are approximately 10,000 active clinical trials globally focused on cancer treatment, involving tens of thousands of patients.
  • Policy and Support

    • Government Initiatives: Many countries are increasing funding for cancer research and treatment programs, with initiatives like the U.S. Cancer Moonshot aiming to accelerate progress in cancer prevention, diagnosis, and treatment.

This report studies the Oncology Drugs market, covering market size for segment by type (Cytotoxic Drugs, Targeted Drugs, etc.), by application (Lung Cancer, Stomach Cancer, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Abbvie, Novartis, Pfizer, Bristol-Myers Squibb, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Oncology Drugs from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Oncology Drugs market.

Leading Players of Oncology Drugs including:

  • Roche
  • Abbvie
  • Novartis
  • Pfizer
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bayer
  • Merck
  • Amgen
  • GlaxoSmithKline
  • BioMerieux
  • Bio-Rad Laboratories
  • Gilead Sciences
  • Including or Excluding key companies relevant to your analysis.
Market split by Type:
  • Cytotoxic Drugs
  • Targeted Drugs
  • Hormonal Drugs
  • Others
Market split by Application:
  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
Market split by Sales Channel:
  • Direct Channel
  • Distribution Channel
Market split by Region/Country:
  • North America (United States and Canada)
  • Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
  • South America (Brazil, Mexico, and Argentina, etc.)
  • Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.

TABLE OF CONTENTS

Table of Contents

Chapter 1 Oncology Drugs Market Overview
1.1 Oncology Drugs Definition
1.2 Global Oncology Drugs Market Size Status and Outlook (2018-2032)
1.3 Global Oncology Drugs Market Size Comparison by Region (2018-2032)
1.4 Global Oncology Drugs Market Size Comparison by Type (2018-2032)
1.5 Global Oncology Drugs Market Size Comparison by Application (2018-2032)
1.6 Global Oncology Drugs Market Size Comparison by Sales Channel (2018-2032)
1.7 Oncology Drugs Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Oncology Drugs Market
Chapter 2 Oncology Drugs Market Competition by Player
2.1 Global Oncology Drugs Sales and Market Share by Player (2021-2023)
2.2 Global Oncology Drugs Revenue and Market Share by Player (2021-2023)
2.3 Global Oncology Drugs Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Oncology Drugs Market Segment by Type
3.1 Global Oncology Drugs Market by Type
3.1.1 Cytotoxic Drugs
3.1.2 Targeted Drugs
3.1.3 Hormonal Drugs
3.1.4 Others
3.2 Global Oncology Drugs Sales and Market Share by Type (2018-2023)
3.3 Global Oncology Drugs Revenue and Market Share by Type (2018-2023)
3.4 Global Oncology Drugs Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Oncology Drugs Market Segment by Application
4.1 Global Oncology Drugs Market by Application
4.1.1 Lung Cancer
4.1.2 Stomach Cancer
4.1.3 Colorectal Cancer
4.1.4 Breast Cancer
4.1.5 Prostate Cancer
4.2 Global Oncology Drugs Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Oncology Drugs Market Segment by Sales Channel
5.1 Global Oncology Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Oncology Drugs Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Oncology Drugs Market Segment by Region & Country
6.1 Global Oncology Drugs Market Size and CAGR by Region (2018-2032)
6.2 Global Oncology Drugs Sales and Market Share by Region (2018-2023)
6.3 Global Oncology Drugs Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Oncology Drugs Market Share by Type
6.4.3 North America Oncology Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Oncology Drugs Market Share by Type
6.5.3 Europe Oncology Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Oncology Drugs Market Share by Type
6.6.3 Asia-Pacific Oncology Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Oncology Drugs Market Share by Type
6.7.3 South America Oncology Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Oncology Drugs Market Share by Type
6.8.3 Middle East & Africa Oncology Drugs Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Oncology Drugs Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Abbvie
7.3 Novartis
7.4 Pfizer
7.5 Bristol-Myers Squibb
7.6 Eli Lilly and Company
7.7 AstraZeneca
7.8 Sanofi
7.9 Bayer
7.10 Merck
7.11 Amgen
7.12 GlaxoSmithKline
7.13 BioMerieux
7.14 Bio-Rad Laboratories
7.15 Gilead Sciences
Chapter 8 Upstream and Downstream Analysis of Oncology Drugs
8.1 Industrial Chain of Oncology Drugs
8.2 Upstream of Oncology Drugs
8.3 Downstream of Oncology Drugs
Chapter 9 Development Trend of Oncology Drugs (2024-2032)
9.1 Global Oncology Drugs Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Oncology Drugs Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Oncology Drugs Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Oncology Drugs Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Oncology Drugs Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

LIST OF TABLES & FIGURES

List of Tables and Figures

Figure Oncology Drugs Example
Figure Global Oncology Drugs Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Oncology Drugs Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Oncology Drugs Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Oncology Drugs Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Oncology Drugs Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Oncology Drugs Sales by Player (2021-2023)
Table Global Oncology Drugs Sales Market Share by Player (2021-2023)
Figure Global Oncology Drugs Sales Market Share by Player in 2023
Table Global Oncology Drugs Revenue (Million $) by Player (2021-2023)
Table Global Oncology Drugs Revenue Market Share by Player (2021-2023)
Figure Global Oncology Drugs Revenue Market Share by Player in 2023
Table Global Oncology Drugs Average Price by Player (2021-2023)
Figure Global Oncology Drugs Average Price by Player in 2023
Figure Global Oncology Drugs Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Oncology Drugs Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of Cytotoxic Drugs
Figure Global Cytotoxic Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Targeted Drugs
Figure Global Targeted Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Hormonal Drugs
Figure Global Hormonal Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2018-2023)
Table Global Oncology Drugs Sales by Type (2018-2023)
Table Global Oncology Drugs Sales Market Share by Type (2018-2023)
Figure Global Oncology Drugs Sales Market Share by Type in 2023
Table Global Oncology Drugs Revenue (Million $) by Type (2018-2023)
Table Global Oncology Drugs Revenue Market Share by Type (2018-2023)
Figure Global Oncology Drugs Revenue Market Share by Type in 2023
Table Global Oncology Drugs Average Price by Type (2018-2023)
Figure Global Oncology Drugs Average Price by Type in 2023
Table Leading Players of Oncology Drugs by Type in 2023
Figure Example of Lung Cancer
Figure Global Oncology Drugs for Lung Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Stomach Cancer
Figure Global Oncology Drugs for Stomach Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Colorectal Cancer
Figure Global Oncology Drugs for Colorectal Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Breast Cancer
Figure Global Oncology Drugs for Breast Cancer Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Prostate Cancer
Figure Global Oncology Drugs for Prostate Cancer Revenue (Million $) and Growth Rate (2018-2023)
Table Global Oncology Drugs Sales by Application (2018-2023)
Table Global Oncology Drugs Sales Market Share by Application (2018-2023)
Figure Global Oncology Drugs Sales Market Share by Application in 2023
Table Leading Consumers of Oncology Drugs by Application in 2023
Figure Example of Direct Channel
Figure Global Oncology Drugs for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Oncology Drugs for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Oncology Drugs Revenue by Sales Channel (2018-2023)
Table Global Oncology Drugs Revenue Market Share by Sales Channel (2018-2023)
Figure Global Oncology Drugs Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Oncology Drugs by Sales Channel in 2023
Table Global Oncology Drugs Market Size and CAGR by Region (2018-2032)
Table Global Oncology Drugs Sales by Region (2018-2023)
Table Global Oncology Drugs Sales Market Share by Region (2018-2023)
Figure Global Oncology Drugs Sales Market Share by Region in 2023
Table Global Oncology Drugs Revenue (Million $) by Region (2018-2023)
Table Global Oncology Drugs Revenue Market Share by Region (2018-2023)
Figure Global Oncology Drugs Revenue Market Share by Region in 2023
Table North America Oncology Drugs Sales by Country (2018-2023)
Figure North America Oncology Drugs Sales Market Share by Country (2018-2023)
Table North America Oncology Drugs Revenue by Country (2018-2023)
Figure North America Oncology Drugs Revenue Market Share by Country (2018-2023)
Figure North America Oncology Drugs Market Share by Type in 2023
Figure North America Oncology Drugs Market Share by Application in 2023
Figure United States Oncology Drugs Sales and Growth Rate (2018-2023)
Figure United States Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Canada Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Oncology Drugs Sales by Country (2018-2023)
Figure Europe Oncology Drugs Sales Market Share by Country (2018-2023)
Table Europe Oncology Drugs Revenue by Country (2018-2023)
Figure Europe Oncology Drugs Revenue Market Share by Country (2018-2023)
Figure Europe Oncology Drugs Market Share by Type in 2023
Figure Europe Oncology Drugs Market Share by Application in 2023
Figure Germany Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Germany Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Oncology Drugs Sales and Growth Rate (2018-2023)
Figure UK Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure France Oncology Drugs Sales and Growth Rate (2018-2023)
Figure France Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Italy Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Spain Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Russia Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Oncology Drugs Sales by Country (2018-2023)
Figure Asia-Pacific Oncology Drugs Sales Market Share by Country (2018-2023)
Table Asia-Pacific Oncology Drugs Revenue by Country (2018-2023)
Figure Asia-Pacific Oncology Drugs Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Oncology Drugs Market Share by Type in 2023
Figure Asia-Pacific Oncology Drugs Market Share by Application in 2023
Figure China Oncology Drugs Sales and Growth Rate (2018-2023)
Figure China Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Japan Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Korea Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure India Oncology Drugs Sales and Growth Rate (2018-2023)
Figure India Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Southeast Asia Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Australia Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Table South America Oncology Drugs Sales by Country (2018-2023)
Figure South America Oncology Drugs Sales Market Share by Country (2018-2023)
Table South America Oncology Drugs Revenue by Country (2018-2023)
Figure South America Oncology Drugs Revenue Market Share by Country (2018-2023)
Figure South America Oncology Drugs Market Share by Type in 2023
Figure South America Oncology Drugs Market Share by Application in 2023
Figure Brazil Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Brazil Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Mexico Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Argentina Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Colombia Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Oncology Drugs Sales by Country (2018-2023)
Figure Middle East & Africa Oncology Drugs Sales Market Share by Country (2018-2023)
Table Middle East & Africa Oncology Drugs Revenue by Country (2018-2023)
Figure Middle East & Africa Oncology Drugs Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Oncology Drugs Market Share by Type in 2023
Figure Middle East & Africa Oncology Drugs Market Share by Application in 2023
Figure Turkey Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Turkey Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Oncology Drugs Sales and Growth Rate (2018-2023)
Figure UAE Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Oncology Drugs Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Oncology Drugs Sales and Growth Rate (2018-2023)
Figure South Africa Oncology Drugs Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of Roche
Table Oncology Drugs Introduction of Roche
Table Oncology Drugs Sales, Price, Revenue, Gross Margin and Market Share of Roche (2021-2023)
Table Industrial Chain of Oncology Drugs
Table Leading Consumers of Oncology Drugs
Figure Global Oncology Drugs Sales and Growth Rate Forecast (2024-2032)
Figure Global Oncology Drugs Revenue and Growth Rate Forecast (2024-2032)
Table Global Oncology Drugs Market Size and CAGR Forecast by Region (2024-2032)
Table Global Oncology Drugs Market Size and CAGR Forecast by Type (2024-2032)
Table Global Oncology Drugs Market Size and CAGR Forecast by Application (2024-2032)
Table Global Oncology Drugs Market Size and CAGR Forecast by Sales Channel (2024-2032)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User License
USD GBP EURO YEN Enterprise License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount